a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders
Industry Biotechnology
A.I.dvisor tells us that PHAT and ALDX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHAT and ALDX's prices will move in lockstep.
Ticker / NAME | Correlation To PHAT | 1D Price Change % | ||
---|---|---|---|---|
PHAT | 100% | -6.77% | ||
ALDX - PHAT | 31% Poorly correlated | -3.17% | ||
TSHA - PHAT | 30% Poorly correlated | +2.71% | ||
SNDX - PHAT | 29% Poorly correlated | +0.96% | ||
OTLK - PHAT | 29% Poorly correlated | -7.55% | ||
ABOS - PHAT | 28% Poorly correlated | +3.16% | ||
More |